American Heart Association 2008 Scientific Sessions: Familial hypercholesterolemia and colesevelam (Welchol)

P and T

Volumn 34, Issue 1, 2009, Pages 32-

  Alexander, Walter ^a   Stein, Evan ^b  

^a University of Cincinnati ^*

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESEVELAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; CHILDHOOD; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONFERENCE PAPER; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FAMILIAL HYPERCHOLESTEROLEMIA; GASTROINTESTINAL DISEASE; GROUPS BY AGE; HEART INFARCTION; HUMAN; INTIMA; MEDICAL SOCIETY; MORTALITY; PATIENT COMPLIANCE; SINGLE DRUG DOSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 60549109248     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (4)

1. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-1965.
2. Ridker P, Danielson, E, Fonseca F, et al., the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
3. Insull W Jr, Toth P, Mullican W, et al. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: A 24-week randomized controlled trial. Mayo Clin Proc 2001;76(10):971-982.
4. Hunninghake D. Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively. Atherosclerosis 2001;158(2):407-416.